<DOC>
	<DOCNO>NCT00865449</DOCNO>
	<brief_summary>This double blind randomize control study evaluate effect aldactone peritoneal fibrosis incident peritoneal dialysis patient . The study would include total 40 incident peritoneal dialysis patient . Peritoneal biopsy would make randomization 6 month intervention evaluate effect renin angiotensin blockade peritoneal fibrosis .</brief_summary>
	<brief_title>Spironolactone Prevention Peritoneal Fibrosis Peritoneal Dialysis</brief_title>
	<detailed_description />
	<mesh_term>Fibrosis</mesh_term>
	<mesh_term>Kidney Failure , Chronic</mesh_term>
	<mesh_term>Peritoneal Fibrosis</mesh_term>
	<mesh_term>Spironolactone</mesh_term>
	<criteria>Age &gt; 18 Hospitalized peritoneal catheter placement peritoneal dialysis Pregnancy Hiperkalemia ( K &gt; 5.5meq/l ) Intolerance spironolactone</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>March 2009</verification_date>
	<keyword>spironolactone</keyword>
	<keyword>peritoneal fibrosis</keyword>
	<keyword>peritoneal dialysis</keyword>
</DOC>